Advertisement
Home »

Mirvetuximab soravtansine-gynx compared to chemotherapy in folate receptor alpha-positive platinum resistant ovarian cancer led to improved survival

Dec 19, 2023

ABOUT THE EXPERTS

Advertisement
Advertisement